ALDH16A1 Antibodies

Santa Cruz Biotechnology provides a broad selection of ALDH16A1 monoclonal antibodies for research focused on understanding aldehyde dehydrogenase 16A1. ALDH16A1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALDH16A1, or aldehyde dehydrogenase 16A1, plays an essential role in aldehyde metabolism and cellular detoxification processes. ALDH16A1 has significant implications in neurological health through its involvement in metabolizing neurotoxic aldehydes. Research has shown that ALDH16A1 expression patterns vary across different tissues and developmental stages. Scientists continue to uncover new functions of ALDH16A1 in cellular homeostasis and stress response. Understanding ALDH16A1 activity provides valuable insights into various diseases and conditions. Ongoing studies of ALDH16A1 reveal its potential as a therapeutic target in multiple disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ALDH16A1 and its impact on human health.